Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sarkozy under fire on flu vaccine ‘fiasco’
FT.com
Tuesday, January 5, 2010 - 6:48am
tags:
France, H1N1, vaccines
Daughter of New York Jets owner, heiress to Johnson & Johnson empire, found dead in her home
Yahoo/AP
Tuesday, January 5, 2010 - 6:47am
tags:
JNJ, Casey Johnson
Alcon: Novartis deal may hurt minority holders
Marketwatch
Tuesday, January 5, 2010 - 6:46am
tags:
Alcon, Novartis, M&A
FDA Delay of Prevnar 13 Could Be Trouble for Pfizer
BNET Pharma
Monday, January 4, 2010 - 2:17pm
tags:
Prevnar 13, Pfizer, vaccines
Dynavax wraps up Symphony Dynamo deal
Bizjournals.com
Monday, January 4, 2010 - 2:16pm
tags:
Dynavax, Symphony Dynamo, cancer
Pfizer Up 3% as Europe Okays Hypertension Drug
Barron's
Monday, January 4, 2010 - 2:15pm
tags:
Europe, hypertension, Pfizer, Revatio
Scrutiny of Drug-Industry Gifts to Docs Goes Global
WSJ Online
Monday, January 4, 2010 - 11:03am
tags:
India, physician gifts
Call Big Pharma a DTC conservative
Fierce Pharma
Monday, January 4, 2010 - 11:02am
tags:
Big Pharma, DTC
Is the Rally for Real? Biotech Sources Argue Yes...and No
BNET Pharma
Monday, January 4, 2010 - 11:01am
tags:
biotech, Genzyme
Valeant Drug Accepted by FDA
Yahoo/Zacks.com
Monday, January 4, 2010 - 10:59am
tags:
Valeant Pharmaceuticals, FDA, retigabine, epilepsy
Does Alcon Deal Stack Up For Novartis?
WSJ Online
Monday, January 4, 2010 - 9:49am
tags:
Alcon, Novartis, M&A
Biotech's Movers and Shakers 2009: BioBuzz
TheStreet.com
Monday, January 4, 2010 - 9:35am
tags:
Biogen Idec, Genzyme, Amgen, Gilead Sciences, Celgene, Vanda, Human Genome Sciences, Keryx, Opexa, CompuGen, Repros Therapeutics, Sequenom, GTx, GTC Biotherapeutics
Anesiva ends 2009 with a bankruptcy petition
Fierce Biotech
Monday, January 4, 2010 - 9:29am
tags:
bankruptcy, Anesiva
Amgen, others may benefit from reform-Barron's
Reuters
Monday, January 4, 2010 - 9:28am
tags:
healthcare reform, Amgen, Alexion
India's Cipla in drug supply talks with GSK, Teva
Reuters
Monday, January 4, 2010 - 9:24am
tags:
GSK, Teva Pharmaceuticals, Boehringer Ingelheim, Cipla, India
Cipher to seek U.S. approval for pain treatment
Reuters
Monday, January 4, 2010 - 9:23am
tags:
Cipher Pharmaceuticals, Canada, FDA
Pfizer's $1.3B Esperion Loss Contained a $426M Tax Win
BNET Pharma
Monday, January 4, 2010 - 9:18am
tags:
Pfizer, Esperion
InterMune gets FDA priority review for pirfenidone
Marketwatch
Monday, January 4, 2010 - 8:49am
tags:
FDA, InterMune, pirfenidone
Senate Likely to Have Edge as Democrats Craft Final Health Bill
Bloomberg
Monday, January 4, 2010 - 8:47am
tags:
healthcare bill, healthcare reform
Pfizer Discontinues Cancer Drug: Biotech's Recently Missed Targets
Seeking Alpha
Monday, January 4, 2010 - 8:45am
tags:
Pfizer, Arena Pharmaceuticals, JNJ, Merck, Trimeris, figitumumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.